Table 4.

Survival, recurrence pattern, DFS, and adjuvant therapy of patients with endometrial stromal sarcoma and adenosarcoma

	Stage	Age	Surgery	Adjuvant therapy	Recurrence	DFS in months	OS in months	Status
1	1A ESS	57	TAH + BSO + PLND	RT+ CT	Lung	10	18	Dead
2	1A ESS	55	TAH + BSO + PLND					Lost to follow up
3	IVA ESS	51	Total pelvic exenteration	Nil	Nil	144	200	Dead due to medical issues
4	IVB ESS	30	Supralevator posterior exenteration	Nil	Mesenteric deposits		4	Dead
5	1A AS	67	Completion hysterectomy + BSO + PLND	Nil	Pelvis	39	56	Dead

ESS endometrial stromal sarcoma, AS adenosarcoma, OS overall survival, DFS disease-free survival, RT radiotherapy, CT chemotherapy, TAH total abdominal hysterectomy, BSO bilateral salpingo-oopherectomy, PLND pelvic lymph nodal dissection